Synergistic anticancer activity of sorafenib, paclitaxel, and radiation therapy on anaplastic thyroid cancer in vitro and in vivo.
Soo-Young KimSeok-Mo KimHojin ChangHang-Seok ChangCheong Soo ParkYong Sang LeePublished in: Head & neck (2020)
These results suggest that the combination of radiation and paclitaxel plus sorafenib has significant anticancer activity in preclinical models.